Current Issue


Self-administered questionnaire may help evaluate patients' cirrhosis knowledge

The questionnaire, which covered medication use and accessibility, medication obstacles, lactulose use, diuretic use, beta-blocker use, and dietary sodium use, was validated in a study of 582 outpatients and 131 inpatients.

IV iron regimens compared for serum phosphate effects in patients with IBD

Ferric carboxymaltose and ferric derisomaltose worked well to resolve anemia from inflammatory bowel disease (IBD), but the former was associated with low serum phosphate levels, according to an industry-funded trial.

High consumption of ultra-processed foods associated with CRC in men

Among women, only consumption of ready-to-eat or -heat mixed dishes was linked to increased risk of colorectal cancer (CRC), according to a new analysis of the Health Professionals Follow-up Study and Nurses' Health Studies.

MKSAP Quiz: CRC surveillance after polyp removal

This month's quiz asks readers to determine the most appropriate colorectal cancer (CRC) surveillance interval in a 60-year-old patient following removal of a 7-mm sessile serrated polyp.

Spotlight on digestive risks of newer diabetes drugs

Recent studies linked the use of glucagon-like peptide-1 receptor agonists to risk of digestive diseases, such as acute cholecystitis.

Aggressive fluid strategy didn't avert progression to severe pancreatitis

The randomized trial was stopped early due to lack of benefit and significantly higher risk of fluid overload in patients receiving an aggressive fluid resuscitation strategy compared to those getting moderate resuscitation.

Glycogenic hepatopathy

A 21-year-old man with type 1 diabetes presented to the hospital with nausea, vomiting, and abdominal pain. Physical exam showed hepatosplenomegaly.

Annals for Hospitalists offers clinical pearls on Clostridioides difficile infection

This month's article reviews the best testing method for diagnostic accuracy, criteria that predict poor outcomes, first-line treatment strategies, prevention of recurrent infection in high-risk patients, and when to offer fecal microbiota transplantation.

Case reports published on gastroenterology, hepatology topics

Reports on purple urine in a patient with chronic constipation, long-term use of metronidazole mimicking hepatic encephalopathy, and chronic lymphocytic leukemia involving the liver were published in the past month.

Monkeypox may be transmitted through fecal microbiota transplantation

Because of this risk, the FDA determined that additional protections are required for any investigational use of fecal microbiota transplantation if it involves stool donated on or after March 15, 2022.

FDA approves first medication for adults with hepatorenal syndrome

The treatment is indicated to improve kidney function in adults with hepatorenal syndrome with rapid reduction in kidney function.

Hepatic artery infusion pumps recalled

The recall was initiated after reports from clinicians that the pumps were delivering medications faster than expected.